Evidence map›Paper›PMID 29138299›Full record

ArticlemBio2017

Induction of Antiviral Immune Response through Recognition of the Repeating Subunit Pattern of Viral Capsids Is Toll-Like Receptor 2 Dependent.

Kelly M Shepardson, Benjamin Schwarz, Kyle Larson, Rachelle V Morton, John Avera, Kimberly McCoy, Alayna Caffrey, Ann Harmsen, Trevor Douglas, Agnieszka Rynda-Apple

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 48 citations in OpenAlex.

  1. AFrontiers in microbiology · 2026
    Article
  2. Article
  3. Article
  4. Molecular pharmaceutics · 2024
    Article
  5. Recognition of Mycobacterium tuberculosis by macrophage Toll-like receptor and its role in autophagy.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Modifying immune responses to adeno-associated virus vectors by capsid engineering.Molecular therapy. Methods & clinical development · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Nonthermal plasma as part of a novel strategy for vaccination.Plasma processes and polymers (Print) · 2020
    Review
  19. Article
  20. Phages in the fight against COVID-19?Future microbiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Kelly M ShepardsonDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.ORCID 0000-0003-3631-2594
Benjamin SchwarzDepartment of Chemistry, Indiana University, Bloomington, Indiana, USA.
Kyle LarsonDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Rachelle V MortonDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
John AveraDepartment of Chemistry, Indiana University, Bloomington, Indiana, USA.
Kimberly McCoyDepartment of Chemistry, Indiana University, Bloomington, Indiana, USA.
Alayna CaffreyDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Ann HarmsenDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA.
Trevor DouglasDepartment of Chemistry, Indiana University, Bloomington, Indiana, USA.
Agnieszka Rynda-AppleDepartment of Microbiology and Immunology, Montana State University, Bozeman, Montana, USA agnieszka.rynda@montana.edu.
Montana State University · USIndiana University Bloomington · US

Funding

Pilot Grants ProgramP30GM110732 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T · 2014 to 2018
$5.4M
Engineered virus-like nanoparticles targeting immunity needed for pan flu vaccineR01AI104905 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI DOUGLAS, TREVOR, JUTILA, MARK A · 2013 to 2017
$2.3M
Development of novel, safe and efficacious Coxiella burnetii vaccineR21AI119772 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI JUTILA, MARK A, RYNDA-APPLE, AGNIESZKA · 2015 to 2016
$396k
NIAID NIH HHS R01 AI104905NIAID NIH HHS R21 AI119772NIGMS NIH HHS P30 GM110732
6 · The paper itself

Abstract

Although viruses and viral capsids induce rapid immune responses, little is known about viral pathogen-associated molecular patterns (PAMPs) that are exhibited on their surface. Here, we demonstrate that the repeating protein subunit pattern common to most virus capsids is a molecular pattern that induces a Toll-like-receptor-2 (TLR2)-dependent antiviral immune response. This early antiviral immune response regulates the clearance of subsequent bacterial superinfections, which are a primary cause of morbidities associated with influenza virus infections. Utilizing this altered susceptibility to subsequent bacterial challenge as an outcome, we determined that multiple unrelated, empty, and replication-deficient capsids initiated early TLR2-dependent immune responses, similar to intact influenza virus or murine pneumovirus. These TLR2-mediated responses driven by the capsid were not dependent upon the capsid's shape, size, origin, or amino acid sequence. However, they were dependent upon the multisubunit arrangement of the capsid proteins, because unlike intact capsids, individual capsid subunits did not enhance bacterial clearance. Further, we demonstrated that even a linear microfilament protein built from repeating protein subunits (F-actin), but not its monomer (G-actin), induced similar kinetics of subsequent bacterial clearance as did virus capsid. However, although capsids and F-actin induced similar bacterial clearance, in macrophages they required distinct TLR2 heterodimers for this response (TLR2/6 or TLR2/1, respectively) and different phagocyte populations were involved in the execution of these responses

Indexed as

Immunity, InnatePathogen-Associated Molecular Pattern MoleculesAnimalsBacteriaCapsidCapsid ProteinsMacrophagesMice, Inbred C57BLMice, KnockoutToll-Like Receptor 2Virus DiseasesVirusesCapsid ProteinsPathogen-Associated Molecular Pattern MoleculesToll-Like Receptor 2bacterial superinfectioninnate immunitypattern recognitionToll-like receptorsvirologyvirus-host interactions

Identifiers

PMID29138299
PMCPMC5686532
OpenAlexW2770956872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.